Norfloxacin Good Manufacturer supply High Quality 70458-96-7
- Molecular Formula:C16H18FN3O3
- Molecular Weight:319.336
- Appearance/Colour:Off-white to light yellow cryst powder
- Vapor Pressure:2.6E-20mmHg at 25°C
- Melting Point:220 °C
- Boiling Point:555.8 °C at 760 mmHg
- PKA:pKa1 6.34; pKa2 8.75(at 25℃)
- Flash Point:289.9 °C
- PSA：74.57000
- Density:1.344 g/cm3
- LogP:1.66210
Norfloxacin (70458-96-7) Usage
Norfloxacin is a fluoroquinolone antibiotic that inhibits the growth of Gram-positive and Gram-negative bacteria (MICs = 4 and 1 μg/ml for S. aureus and P. aeruginosa, respectively). It also inhibits the growth S. pseudintermedius, S. aureus, E. coli, Pasturella, and S. canis isolates from dogs (mean MIC50s = 0.25, 1, 0.03, 1, and 1 μg/ml, respectively). Topical administration of norfloxacin (0.1% v/v) reduces corneal ulcer size in a rabbit model of P. aeruginosa corneal infection. It also prevents encrusted cystitis in bladder and increases survival in a rat model of Corynebacterium group D2 infection when administered at a dose of 80 mg/kg per day. Formulations containing norfloxacin have been used to treat urinary tract and gynecological infections.
How to get the best price on Norfloxacin?
Zibo Hangyu Biotechnology Development Co., Ltd is a quality supplier and manufacturer of Norfloxacin . You can buy high quality, low price Norfloxacin 70458-96-7 here.
Zibo Hangyu Biotechnology Development Co., Ltd. is a comprehensive chemical enterprise focusing on fine chemical products and pharmaceutical intermediates, integrating research and development, production and sales. The company is equipped with advanced equipment quality inspection and research center. At the same time, the company has excellent talents with rich experience in process development and quality control. To provide customers with total solutions from raw material processing to chemical synthesis systems. The company has established a standardized and perfect quality standard system to provide stable and high quality production and service.
Milestones
- 2012yearThe company was founded, began to engage in the production and supply of chemical raw materials
- 2014yearExpand the scale of production, pharmaceutical raw materials production workshop was established
- 2016yearCooperated with domestic and foreign chemical platforms to promote self-produced and high-end pharmaceutical intermediates
- 2019yearIn recent years to participate in the international pharmaceutical raw materials exhibitions
- 2023yearBusiness continues to expand, Production and Sales teams continue to grow
- 2026yearPlans to set up foreign branches
![tert‐butyl N‐[(2S)‐1‐[(2S,4R)‐4‐hydroxy‐2‐({[4‐(4‐methyl‐1,3‐thiazol‐5‐yl)phenyl]methyl}carbamoyl)pyrrolidin‐1‐yl]‐3,3‐dimethyl‐1‐oxobutan‐2‐yl]carbamate](/upload/2024/6/c58eb584-a400-422b-b9f8-29d7abc3bad6.png)
